September 27, 2023
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there’s a better way to safely and effectively bring real relief to patients, advancing accessible therapies to prescribers and payers, and providing peace of mind to parents and caregivers. Verrica is focused on innovation, changing the narrative around viral skin diseases, and making treatment a more efficient process for both physicians and patients.
Verrica Pharmaceuticals is committed to the development and commercialization of novel treatments that provide significant benefit for people living with skin diseases. Our clinical programs are developed with an understanding of the patient journey and the healthcare-provider landscape. It is our mission to develop treatment solutions for the millions of underserved patients who have had few options for satisfactory medical care and attention.
Listening, learning and leading the way, Verrica Pharmaceuticals values a commitment to innovative dermatology therapeutics and the ability to deliver ideas and results with speed and agility. We foster an all-hands-on-deck mindset among our employees, enabling everyone with the voice and opportunity to take ownership of their work, and become a vital stakeholder with the company.
Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum
October 11th, 2023 | 11:00 AM ET